MARK MCDADE
CIK 1242126 · CEO · last filed 2025-10-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$38.0K
Companies
10
Total Filings
51
Lifetime Open-Market Net
$1.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tourmaline Bio, Inc. (TRML) Delisted | Director | 0 | $47.98 | $0 | $3.25M | 4 | 2025-10-28 |
| Icosavax, Inc. (ICVX) Delisted | Director | 0 | $15.31 | $0 | $299.8K | 4 | 2024-02-20 |
| Tourmaline Bio, Inc. (TALS) Delisted | Director | — | $27.20 | — | $0 | 2 | 2023-06-14 |
| COLL | Director | 0 | $34.64 | $0 | $0 | 6 | 2020-10-14 |
| DERM | Director | 6,000 | $6.34 | $38.0K | $0 | 6 | 2019-06-14 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | 10,162 | $178.75 | $1.82M | $0 | 4 | 2018-05-14 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | — | $38.00 | — | $0 | 2 | 2016-03-17 |
| Aimmune Therapeutics, Inc. (AIMT) Delisted | Director | 16,660 | — | — | $266.6K | 1 | 2015-08-11 |
| CYTK | Director | — | $70.15 | — | $0 | 4 | 2009-05-22 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | CEO | 46,275 | — | — | -$2.03M | 9 | 2007-07-24 |
Recent Filings · Page 2 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-05 | Icosavax, Inc. (ICVX) Delisted | Buy (P) | +42,225 | $299.8K | EDGAR |
| 2020-10-14 | COLL | Mixed | −34,692 | -$1.20M | EDGAR |
| 2020-05-29 | COLL | Grant (A) | +7,840 | $0 | EDGAR |
| 2020-02-24 | — | Disp (D) | −6,000 | -$112.5K | |
| 2019-06-14 | DERM | Exer (M) | +3,000 | $0 | EDGAR |
| 2019-06-06 | DERM | Grant (A) | — | $0 | EDGAR |
| 2019-05-28 | COLL | Grant (A) | +6,442 | $0 | EDGAR |
| 2018-11-06 | — | Disp (D) | −6,464 | -$145.7K | |
| 2018-08-08 | — | Grant (A) | +1,097 | $0 | |
| 2018-06-14 | DERM | Mixed | +3,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.